Your institution may have access to this item. Find your institution then sign in to continue.
Title
An extended-release dosage form of the selective serotonin reuptake inhibitor (SSRI) fluvoxamine...
Abstract
Reports that Elan Corp. and Solvay Pharmaceuticals is developing an extended-release dosage form of the selective serotonin-reuptake inhibitor fluvoxamine.